Indoco Profits Triple In First Quarter
As FDA Approves Indian Firm’s Rival To Eli Lilly’s Zyprexa
Indoco has tripled its operating profit in its financial first quarter ended 30 June 2020. The company has also received FDA approval for its generic version of Eli Lilly’s Zyprexa.
